1. Home
  2. NBR vs TNDM Comparison

NBR vs TNDM Comparison

Compare NBR & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nabors Industries Ltd.

NBR

Nabors Industries Ltd.

SELL

Current Price

$76.41

Market Cap

1.2B

Sector

Energy

ML Signal

SELL

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

SELL

Current Price

$16.52

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NBR
TNDM
Founded
1952
2006
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
NBR
TNDM
Price
$76.41
$16.52
Analyst Decision
Hold
Buy
Analyst Count
8
25
Target Price
★ $107.38
$27.76
AVG Volume (30 Days)
172.8K
★ 2.1M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 177.74
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $1,014,736,000.00
Revenue This Year
$5.28
$5.69
Revenue Next Year
$9.51
$12.35
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.93
52 Week Low
$39.22
$12.26
52 Week High
$112.90
$29.65

Technical Indicators

Market Signals
Indicator
NBR
TNDM
Relative Strength Index (RSI) 36.42 43.86
Support Level $75.54 $14.66
Resistance Level $84.71 $16.50
Average True Range (ATR) 3.03 0.85
MACD -0.08 0.15
Stochastic Oscillator 16.16 63.38

Price Performance

Historical Comparison
NBR
TNDM

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Share on Social Networks: